This compound is a pharmaceutical intermediate primarily used in the synthesis of benzimidazolone derivatives. Its structure includes an amide group and aromatic rings, contributing to its role in pharmaceutical manufacturing.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 26576-46-5
3-(methyl(nitroso)amino)-1-phenylpropan-1-ol
Nitrosamine impurity standard
3-CHLORO-6,11-DIHYDRO-6-METHYL-5,5,11-TRIOXODIBENZO[C,F][1,2]THIAZEPINE
pharmaceutical intermediate
3,11-dichloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepine 5,5-dioxide
Pharmaceutical intermediate for research
4,4-Dimethyl-1,3-oxazolidin-2-one
pharmaceutical intermediate
4-(2-OXO-2,3-DIHYDRO-1H-BENZIMIDAZOL-1-YL)BUTANOIC ACID
pharmaceutical intermediate
1,3-Dihydro-5-hydroxy-2H-benzimidazol-2-one
Research compound
1,3-Dihydro-5,6-diamino-2H-benzimidazol-2-one
Pharmaceutical intermediate
2-hydroxy benzimidazole
chemical intermediate
3-oxo-N-(2-oxo-1,3-dihydrobenzimidazol-5-yl)butanamide
VEMDQCGHZNXORX-UHFFFAOYSA-N
CC(=O)CC(=O)NC1=CC2=C(C=C1)NC(=O)N2
—